Skip to main navigation Skip to search Skip to main content

MEDERA's SARDOCOR ANNOUNCES FAST TRACK DESIGNATION AND DOSING OF 3 PATIENTS IN FIRST-IN-HUMAN Hfpef GENE THERAPY TRIAL

Press/Media

Period14 Feb 2024

Media coverage

2

Media coverage

  • TitleMEDERA's SARDOCOR ANNOUNCES FAST TRACK DESIGNATION AND DOSING OF 3 PATIENTS IN FIRST-IN-HUMAN Hfpef GENE THERAPY TRIAL
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date14/02/24
    PersonsKevin Costa, Roger Hajjar,
  • TitleMEDERA's SARDOCOR ANNOUNCES FAST TRACK DESIGNATION & DOSING OF 3 PATIENTS IN FIRST-IN-HUMAN GENE THERAPY CLINICAL TRIAL
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date14/02/24
    PersonsKevin Costa, Roger Hajjar,